HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanuelle Varon Selected Research

Pharmaceutical Preparations

1/2022Shift in Clinical Profile of Hospitalized Pneumonia in Children in the Non-pharmaceutical Interventions Period During the COVID-19 Pandemic: A Prospective Multicenter Study.
1/2016Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study.
6/2015Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanuelle Varon Research Topics

Disease

14Pneumococcal Infections
01/2022 - 04/2011
13Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
01/2021 - 11/2006
11Otitis Media
01/2019 - 11/2006
4Pneumonia (Pneumonitis)
01/2022 - 12/2018
4Infections
01/2021 - 09/2006
3Meningitis
02/2022 - 01/2005
3Bacterial Meningitis
01/2021 - 01/2005
3Respiratory Tract Infections (Respiratory Tract Infection)
08/2013 - 10/2005
2COVID-19
01/2022 - 07/2020
2Bacteremia
01/2021 - 12/2018
2Pleural Empyema (Pyothorax)
11/2019 - 04/2006
2Conjunctivitis
01/2018 - 07/2014
2Empyema
01/2016 - 04/2006
2Otitis
06/2015 - 07/2014
1Human Influenza (Influenza)
01/2022
1Chickenpox
08/2021
1Disease Progression
01/2021
1Sepsis (Septicemia)
12/2019
1Shock
12/2019
1Pleural Effusion (Pleural Effusions)
01/2019
1Spontaneous Perforation
01/2019
1Critical Illness (Critically Ill)
12/2018
1Septic Shock (Toxic Shock Syndrome)
12/2018
1Virus Diseases (Viral Diseases)
01/2016
1Communicable Diseases (Infectious Diseases)
12/2014
1Bruton type agammaglobulinemia
07/2014
1MYD88 Deficiency
07/2014
1Ventilator-Associated Pneumonia
07/2004
1Healthcare-Associated Pneumonia
07/2004

Drug/Important Bio-Agent (IBA)

29Conjugate VaccinesIBA
01/2022 - 11/2006
13Anti-Bacterial Agents (Antibiotics)IBA
01/2018 - 07/2004
11VaccinesIBA
02/2022 - 06/2015
410-valent pneumococcal conjugate vaccineIBA
01/2022 - 01/2017
3Biological ProductsIBA
01/2022 - 12/2017
3Pharmaceutical PreparationsIBA
01/2022 - 06/2015
3Amoxicillin (Wymox)FDA LinkGeneric
01/2021 - 06/2015
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
01/2018 - 06/2015
2Penicillins (Penicillin)FDA Link
01/2018 - 11/2006
2insulin receptor-related receptor (IRR)IBA
01/2017 - 08/2013
2AntigensIBA
04/2006 - 01/2005
1Neutralizing AntibodiesIBA
01/2021
1DaptomycinFDA Link
01/2021
1Cefotaxime (Kendrick)FDA LinkGeneric
01/2021
1Rifampin (Rifampicin)FDA LinkGeneric
01/2021
1RNA (Ribonucleic Acid)IBA
07/2020
1protein C activator peptideIBA
12/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016
1AntipyreticsIBA
01/2016
1Third Generation CephalosporinsIBA
06/2015
1Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA
07/2014
1Complement System Proteins (Complement)IBA
07/2014
1Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA
05/2014
1PrebioticsIBA
08/2013
1Streptococcus pneumoniae plY proteinIBA
04/2006
1Ribosomal DNA (rDNA)IBA
04/2006

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
12/2019 - 07/2004
2Therapeutics
09/2006 - 01/2005
1Medical Day Care (Partial Hospitalization)
01/2018
1Joint Prosthesis
09/2006
1Hip Prosthesis
09/2006
1Catheters
07/2004